Bill
H 173
Massachusetts bill regulates Delta-9 THC product potency, labeling, and sales standards to address unregulated hemp-derived cannabis products in retail markets.
H.173 establishes regulatory frameworks for Delta-9 THC products in Massachusetts, addressing the legal gray area created by federally legal hemp-derived cannabinoids. The bill seeks to clarify state oversight of Delta-9 THC concentrations, labeling requirements, and product standards for items sold outside the state's licensed cannabis system. This follows the emergence of unregulated Delta-9 products that exploit federal farm bill loopholes.
Delta-9 THC products (derived from hemp rather than cannabis plants) have flooded retail markets, creating consumer safety concerns around potency accuracy, contamination risks, and youth access—all without state oversight. Clear regulation protects public health by establishing testing and labeling standards while preventing regulatory arbitrage that undermines the state's licensed cannabis market. The bill also clarifies tax and licensing responsibilities for retailers.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
